Back

First-line pharmacological treatment of vasovagal syncope based on syndrome phenotype

7 April 2024 (08:30 - 15:00)
Organised by: Logo
Congress Presentation Part of: Syncope Treatment EHRA Premium Access EHRA 2024 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Doctor Panayota Flevari

Attikon University Hospital, Athens (Greece)

7 More presentations in this session

Presentation thumbnail
A novel predictive model for differentiating cardiac and non-cardiac syncope in syncope-admitted patients
Doctor S. Wu (Beijing, CN)
Abstract Slides Video
Presentation thumbnail
Cardioneuroablation for asystolic reflex syncope with or without the use of extra cardiac vagal stimulation-one year follow-up results.
Doctor R. Piotrowski (Warsaw, PL)
Abstract Slides Video
Presentation thumbnail
Differential and synergistic effects of left and right atrial ablation of paraseptal ganglionated plexuses in a cohort of consecutive patients undergoing cardioneuroablation
Doctor D. Viveros (Barcelona, ES)
Abstract Slides Video
Presentation thumbnail
Cardioneuroablation for vasovagal syncope. Results from an EHRA Survey
Mr D. Penela (Barcelona, ES)
Abstract Slides Video
Presentation thumbnail
Long-term impact of the implementation of a syncope unit: 14 years of care optimization
Doctor F. Rodriguez Entem (Santander, ES)
Abstract Slides Video

Access the full session

Session thumbnail
Syncope

The Event

Event poster

EHRA 2024

7 April - 9 April 2024
You may be interested in
thumbnail
Congress Presentation
Is there a role for pharmacological treatment of syncope?
thumbnail
Congress Presentation
How to manage patients with hypotensive phenotype?
thumbnail
Congress Session
A practical guide to personalised treatment of non-cardiac syncope

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources